| Name |
Urokinase (JP18/USAN/INN);Abbokinase (TN) |
| Class |
Blood modifier agent DG01950 Antithrombotic agent DG01707 Fibrinolytic DG01701 Urokinase-type plasminogen activator |
| Remark |
Therapeutic category: 3954ATC code: B01AD04Chemical structure group: DG00162Product (DG00162): D03341<JP> |
| Efficacy |
Thrombolytic, Fibrinolytic, Urokinase plasminogen activator (u-PA) |
| Comment |
urokinase plasminogen activator (u-PA) [HSA:5328] [KO:K01348] [EC:3.4.21.73] |
| Interaction |
|
| Structure map |
map07049 Antithrombosis agents |
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303] B BLOOD AND BLOOD FORMING ORGANS B01 ANTITHROMBOTIC AGENTS B01A ANTITHROMBOTIC AGENTS B01AD Enzymes B01AD04 Urokinase D03341 Urokinase (JP18/USAN/INN) Therapeutic category of drugs in Japan [BR:br08301] 3 Agents affecting metabolism 39 Other agents affecting metabolism 395 Enzyme preparations 3954 Urokinases D03341 Urokinase (JP18/USAN/INN)Drug groups [BR:br08330] Blood modifier agent DG01950 Antithrombotic agent DG01707 Fibrinolytic DG01701 Urokinase-type plasminogen activator DG00162 Urokinase D03341 UrokinaseDrugs listed in the Japanese Pharmacopoeia [BR:br08311] Chemicals D03341 UrokinaseDrug groups [BR:br08330] Blood modifier agent DG01950 Antithrombotic agent DG01707 Fibrinolytic DG01701 Urokinase-type plasminogen activator DG00162 Urokinase |
| Other DBs |
CAS: 9039-53-6PubChem: 17397491 |
| LinkDB |
|